McMahon Gerald PhD 4
4 · Celldex Therapeutics, Inc. · Filed Dec 4, 2018
Insider Transaction Report
Form 4
McMahon Gerald PhD
Director
Transactions
- Tax Payment
Common Stock, par value $0.001
2018-12-03$0.30/sh−2,824$843→ 180,697 total
Footnotes (2)
- [F1]On November 28, 2016, in connection with the Reporting Person's employment severance agreement the ("Severance Agreement") with Celldex Therapeutics, Inc. ("Issuer") whereby Issuer agreed to pay Reporting Person 267,356 shares of its common stock, par value $0.001 per share ("Common Stock") less required tax and other withholdings ("Withholdings".) The Reporting Person previously reported ownership of such 267,356 shares on his Form 3 filed with the Securities and Exchange Commission on December 15, 2016. The shares, less Withholdings, are issuable to Reporting Person in equal installments through December 2018.
- [F2]Pursuant to the Severance Agreement, on December 3, 2018, the Issuer issued 5,343 shares of its Common Stock to the Reporting Person. This Form 4 reflects the disposition to the Issuer of 2,824 shares of its Common Stock to satisfy required Withholdings in connection with such issuance of its Common Stock to the Reporting Person.